Signum Biosciences, Inc

Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from our phosphatase platform to modulate signal transduction imbalances. Signums phosphatase technology provides many opportunities for the development of novel pharmaceutical therapeutics. Signum has established a robust IP portfolio in the area of Signal Transduction Modulators (STMs). Signal transduction networks that regulate cellular activities have built-in global control mechanisms to coordinate their many interacting components. Signum has identified agents that perturb the two most central of these global regulatory mechanisms: G-Protein-Mediated membrane receptor signaling and Protein phosphorylation. G-Protein modulators (GPMs) regulate virtually all G-protein-mediated signaling activities and...

Healthcare,dermatology,acne,biotechnology,and neutraceuticals

Signum biosciences, inc operates in the Biotechnology research industry.

Signum biosciences, inc's revenue is 11m - 100m

Signum biosciences, inc has 11 - 50 employees.